(Q41062756)

English

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

author name string

Fujita H

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Senju S

2

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Yokomizo H

3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Saya H

4

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Ogawa M

5

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Matsushita S

6

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Nishimura Y

7

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

305-316

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Cancer antigens: immune recognition of self and altered self

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

How can cryptic epitopes trigger autoimmunity?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Biological implications of HLA-DR expression in tumours

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

MHC class II restricted tumor antigens and the role of CD4+ T cells in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Peptide‐specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K‐ras p21

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Antibodies against p53 are associated with poor prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Nomenclature for factors of the HLA system, 1994.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j 1)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Metalloproteinase-mediated release of human Fas ligand

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

p53, a potential target for tumor-directed T cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Dominance and crypticity of T cell antigenic determinants

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

The T cell repertoire against cryptic self determinants and its involvement in autoimmunity and cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

DNA damage, p53 and anticancer therapies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Augmentation of immune response by an analog of the antigenic peptide in a human T-cell clone recognizing mutated Ras-derived peptides

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Generation of CD4+ cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Serum p53 antibodies as early markers of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Serologic dissection of HLA-D specificities by the use of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Detection of a novel HLA-DQ specificity: serological and immunochemical analyses by a monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291521-4141%28199801%2928%3A01%3C305%3A%3AAID-IMMU305%3E3.0.CO%3B2-3

21 January 2018

Identifiers

10.1002/(SICI)1521-4141(199801)28:01<305::AID-IMMU305>3.0.CO;2-3

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

release_mesh2iqflzhrlg4g3x7nzreiem

1 reference

https://api.fatcat.wiki/v0/release/mesh2iqflzhrlg4g3x7nzreiem

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41062756&oldid=1914240253"